| Product NDC: | 55648-140 |
| Proprietary Name: | Lansoprazole |
| Non Proprietary Name: | Lansoprazole |
| Active Ingredient(s): | 15 mg/1 & nbsp; Lansoprazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55648-140 |
| Labeler Name: | Wockhardt Limited |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA202727 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120518 |
| Package NDC: | 55648-140-00 |
| Package Description: | 4500 CAPSULE, DELAYED RELEASE in 1 POUCH (55648-140-00) |
| NDC Code | 55648-140-00 |
| Proprietary Name | Lansoprazole |
| Package Description | 4500 CAPSULE, DELAYED RELEASE in 1 POUCH (55648-140-00) |
| Product NDC | 55648-140 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Lansoprazole |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120518 |
| Marketing Category Name | ANDA |
| Labeler Name | Wockhardt Limited |
| Substance Name | LANSOPRAZOLE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |